Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins

Circulation

Volumn 92, Issue 3, 1995, Pages 415-420

  Guilherme, L ^a   Cunha Neto, E ^a   Coelho, V ^a   Snitcowsky, R ^a   Pomerantzeff, P M A ^a   Assis, R V ^a   Pedra, F ^a   Neumann, J ^a   Goldberg, A ^a   Patarroyo, M E ^b   Pileggi, F ^a   Kalil, J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

autoimmunity; group A hemolytic streptococci; molecular mimicry; rheumatic heart disease; T cell clones

Indexed keywords

BACTERIAL PROTEIN; M PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; CELL CLONE; CROSS REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; T LYMPHOCYTE;

EID: 0029162757     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.3.415     Document Type: Article

References (40)

1. Stollerman GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol. 1991;61:131-142. Short Analytical Review.
2. Dale JB, Beachey EH. Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med. 1982;156:1165-1176.
3. Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med. 1985;162:583-591.
4. Fenderson PG, Fischetti VA, Cunningham MW. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol. 1989;142:2475-2481.
5. Robinson JH, Kehoe MA. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today. 1992;13: 362-367.
6. Raizada V, Williams RC Jr, Chopra P, Gopinath N, Prakash K, Sharma KB, Cherian KM, Panday S, Arora R, Nigam M, Zabriskie JB, Husby G. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med. 1983;74:90-96.
7. Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol. 1989;52:225-237.
8. Dale JB, Simpson WA, Ofek I, Beachey E. Blastogenic responses of human lymphocytes to structurally defined polypeptide fragments of streptococcal M protein. J Immunol. 1981;126:1499-1505.
9. Kotb M, Courtney HS, Dale JB, Beachey EH. Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M proteins. J Immunol. 1989;142:966-970.
10. Tomai M, Kotb M, Majumdar G, Beachey EH. Superantigenicity of streptococcal M protein. J Exp Med. 1990;172:359-362.
11. Tomai MA, Schlievert PM, Kotb M. Distinct T-cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun. 1992;60:701-705.
12. Watanabe-Ohnishi R, Aelion J, Legros L, Tomai MA, Sokurenko EV, Newton D, Takahara J, Irino S, Rashed S, Kotb M. Characterization of unique human TCR Vβ specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol. 1994;152:2066-2073.
13. Mackenzie WA, Scharts AE, Friedman EW, Davies TF. Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 1986;64:818-824.
14. Quaile A, Kejeldsen-kragh J, Forre O, Waalen K, Sioud M, Kafvenes C, Natvig JB. Immunoregulatory T cell activation in rheumatoid arthritis: a need for analysis on the clonal and molecular level. Springer Semin Immunopathol. 1989;11:273-287.
15. Conceição-Silva FR, Dorea R, Pirmez C, Schuhbach A, Coutinho SG. Quantitative study of Leishmania brasiliensis brasilienses reactive T cells in peripheral blood and in the lesions of patients with Americam mucocutaneous leishmaniasis. Clin Exp Immunol. 1990;79:221-226.
16. Padula SJ, Pollard MK, Lingenheld EG, Clark RB. Maintenance of antigen specificity by human interleukin-2 dependent T cell lines. J Clin Invest. 1985;75:788-797.
17. Weber T, Kaufman C, Zeevi A, Zerbi TR, Hardesty RJ, Kormos RH, Griffith BP, Duquesnoy RJ. Lymphocyte growth from cardiac allograft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode. Heart Transplant. 1989;8:233-240.
18. Manjula BN, Acharya AS, Mische MS, Fairwell T, Fischetti VA. The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J Biol Chem. 1984;259:3686-3693.
19. Phillips GN Jr, Flicker PF, Cohen C, Manjula BN, Fischetti VA. Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Nutl Acad Sci USA. 1981;78: 4689-4693.
20. Houghten RA. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A. 1985;82:5131-5135.
21. Molano A, Segura C, Gusman F, Lozada D, Patarroyo ME. In human malaria protective antibodies are directed mainly against the Lys-Glu ion pair within Lys-Glu-Lys motif of the synthetic vaccine sPf66. Parasite Immunol. 1992;14:111-124.
22. Abou-Zeid C, Filley E, Steele J, Rook GAW. A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes 'in vitro' after converting bands cut from Western blots into antigen-bearing particles. J Immunol Methods. 1987;98:5-10.
23. Patarroyo ME, Amador R, Clavijo AP, Moreno A, Guzman F, Romero P, Tascon R, Franco A, Murillo LA, Ponton G, Trujillo G. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 1988;332: 158-161.
24. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med. 1991;325:783-793.
25. Read SE, Fischetti VA, Utermohlen V, Falk RF, Zabriskie JB. Cellular reactivity studies to streptococcal antigens: migration inhibition studies in patients with streptococcal infection and rheumatic fever. J Clin Invest. 1974;54:439-450.
26. Dale JB, Beachey EH. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J Exp Med. 1986;163:1191-1201.
27. Cunningham MW, McCormack JM, Fenderson PG, Beachey EH, Dale JB. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol. 1989;143:2677-2683.
28. Robinson JH, Atherton MC, Goodacre JA, Pinkney M, Weigthman H, Kehoe MA. Mapping T cell epitopes in group A streptococcal type 5 M protein. Infect Immun. 1991;59:4324-4331.
29. Life PF, Bassey EO, Hill Gaston JS. T cell recognition of bacterial heat shock proteins in inflammatory arthritis. Immunol Rev. 1991; 121:113-135.
30. Manjula BN, Trus BL, Fischettti V. Presence of two distinct regions in the coiled-coil structure of the streptococcal pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A. 1985;82:1064-1068.
31. Gulizia JM, Cunningham MW, McManus BM. Immunoreactivity of anti-streptococcal monoclonal antibodies to human heart valves: evidence for multiple cross-reactive epitopes. Am J Pathol. 1991;138:285-301.
32. Ayoub EM, Barret DJ, Maclaren NK, Krischen JP. Association of class II histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest. 1986;77:2019-2026.
33. Anastasiou-Nana M, Anderson JL, Carlquist JF, Nanas JN. HLA DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J. 1986;112:992-997.
34. Jhinghan B, Mehra NK, Reddy KS, Taneja V, Vaidya MC, Bhatia ML. HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens. 1986;27:172-178.
35. Rajapakse CNA, Halim K, Al-Orainey L, Al-Nozha M, Aska AK. A genetic marker for rheumatic heart disease. Br Heart J. 1987;58: 659-662.
36. Maharaj B, Hammond MG, Appadoo B, Leary WP, Pudifin DJ. HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation. 1987;76:259-261.
37. Guilherme L, Weideback W, Kiss MH, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation. 1991;83:1995-1998.
38. Weidbach W, Goldberg AC, Chiarella J, Guilherme L, Snitcowsky R, Pileggi F, Kalil J. HLA class II antigens in rheumatic fever: analysis of the DR locus by restriction fragment length polymorphism and oligotyping. Hum Immunol. 1994;40:253-258.
39. O'Sullivan D, Arrhenius T, Sidney J, Del Guercio MF, Albertson M, Wall M, Oseroff C, Southwood S, Colon SM, Gaeta FCA, Sette A. On the interaction of promiscuous antigenic peptides with different alleles: identification of common structural motifs. J Immunol. 1991;147:2663-2669.
40. Chicz MR, Urban RG, Gorga JC, Vignali DAA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 1993;178: 27-47.